PH11041A - 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof - Google Patents

3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof

Info

Publication number
PH11041A
PH11041A PH14508A PH14508A PH11041A PH 11041 A PH11041 A PH 11041A PH 14508 A PH14508 A PH 14508A PH 14508 A PH14508 A PH 14508A PH 11041 A PH11041 A PH 11041A
Authority
PH
Philippines
Prior art keywords
phenethylamine
dihydroxy
salts
alkyl
substituted phenyl
Prior art date
Application number
PH14508A
Other languages
English (en)
Inventor
J Mills
R Tuttle
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH11041(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH11041A publication Critical patent/PH11041A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH14508A 1972-04-12 1973-04-12 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof PH11041A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
PH11041A true PH11041A (en) 1977-10-25

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
PH14508A PH11041A (en) 1972-04-12 1973-04-12 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof

Country Status (31)

Country Link
JP (2) JPS5825656B2 (ro)
KR (1) KR790000113B1 (ro)
AR (1) AR203822A1 (ro)
AT (1) AT323719B (ro)
AU (1) AU472734B2 (ro)
BE (1) BE798051A (ro)
BG (1) BG23001A3 (ro)
CA (1) CA1018188A (ro)
CH (2) CH580563A5 (ro)
CS (2) CS190406B2 (ro)
CY (1) CY963A (ro)
DD (1) DD107670B3 (ro)
DE (1) DE2317710C2 (ro)
DK (1) DK142750C (ro)
ES (1) ES413639A1 (ro)
FR (1) FR2182947B1 (ro)
GB (1) GB1392674A (ro)
HK (1) HK50178A (ro)
HU (2) HU167597B (ro)
IE (1) IE37511B1 (ro)
IL (1) IL42016A (ro)
KE (1) KE2870A (ro)
MY (1) MY7800381A (ro)
NL (1) NL174459C (ro)
PH (1) PH11041A (ro)
PL (2) PL90695B1 (ro)
RO (2) RO65105A (ro)
SE (1) SE399064B (ro)
SU (1) SU496719A3 (ro)
YU (2) YU36483B (ro)
ZA (1) ZA732136B (ro)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (ro) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
EP0071399A3 (en) * 1981-07-22 1983-12-07 Syntex (U.S.A.) Inc. Substituted pyrrolidine cardiovascular system regulators and antihypertensives, their preparation and use
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (ro) * 1989-12-18 1991-08-23
CA2103367A1 (en) * 1991-05-20 1992-11-21 Akihide Koda Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
EP1546088B1 (en) 2002-10-03 2014-12-17 Novaremed Ltd. Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
JP4939396B2 (ja) * 2004-03-26 2012-05-23 ノヴァレメッド リミテッド Aids及び他のウイルス性疾患及びhiv関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
SG178191A1 (en) 2009-07-31 2012-03-29 Cognition Therapeutics Inc Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
CA2846604A1 (en) * 2011-08-25 2013-02-28 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
ES2915833T3 (es) 2014-01-31 2022-06-27 Cognition Therapeutics Inc Composiciones de isoindolina y métodos para tratar una enfermedad neurodegenerativa y una degeneración macular
CA3061787A1 (en) 2017-05-15 2018-11-22 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实(湖南)医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
YU37113B (en) 1984-08-31
PL94207B1 (ro) 1977-07-30
NL174459B (nl) 1984-01-16
DE2317710C2 (de) 1983-08-04
BE798051A (fr) 1973-10-11
DE2317710A1 (de) 1973-10-18
DD107670B3 (de) 1988-04-06
AU5438573A (en) 1974-10-17
YU321279A (en) 1983-04-27
FR2182947A1 (ro) 1973-12-14
JPS5825656B2 (ja) 1983-05-28
SU496719A3 (ru) 1975-12-25
RO65105A (ro) 1980-01-15
HU167597B (ro) 1975-11-28
CA1018188A (en) 1977-09-27
AR203822A1 (es) 1975-10-31
HU166213B (ro) 1975-02-28
NL174459C (nl) 1984-06-18
CH569691A5 (ro) 1975-11-28
HK50178A (en) 1978-09-15
RO70892A (ro) 1982-02-26
ZA732136B (en) 1974-03-27
KE2870A (en) 1978-09-01
YU97673A (en) 1982-02-25
PL90695B1 (ro) 1977-01-31
CY963A (en) 1978-12-22
KR790000113B1 (en) 1979-03-20
IL42016A0 (en) 1973-06-29
JPS497237A (ro) 1974-01-22
MY7800381A (en) 1978-12-31
AT323719B (de) 1975-07-25
AU472734B2 (en) 1976-06-03
DD107670A5 (de) 1974-08-12
IE37511B1 (en) 1977-08-03
YU36483B (en) 1984-02-29
DK142750B (da) 1981-01-12
IL42016A (en) 1976-05-31
NL7305097A (ro) 1973-10-16
ES413639A1 (es) 1976-01-16
CS190448B2 (en) 1979-05-31
JPS6221343B2 (ro) 1987-05-12
SE399064B (sv) 1978-01-30
CS190406B2 (en) 1979-05-31
BG23001A3 (ro) 1977-05-20
JPS58131945A (ja) 1983-08-06
GB1392674A (en) 1975-04-30
DK142750C (da) 1981-08-17
FR2182947B1 (ro) 1976-07-02
CH580563A5 (ro) 1976-10-15

Similar Documents

Publication Publication Date Title
PH11041A (en) 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof
KE2930A (en) Substituted 16,17,18,19,20-pentanorprostaglandins
PH12617A (en) Aminobenzyl-amides and salts thereof
KE2670A (en) 1,2,3,-thiadiazole derivatives
PH12918A (en) 1,3-dioxo-2-aminoalkyl-4,4-dimethyl-isoquinolines and salts thereof
IL36949A (en) Substituted,2,2-diaryl-4-piperidinobutyramides and salts thereof and their preparation
AU3031771A (en) New 2 amino-4-phenyl-thiazoles and their addition salts
GB1406961A (en) 2,4,7-trioxopteridine derivatives
ZA734996B (en) Oral composition
AU5852873A (en) Cardenolide-3-%2@-desoxy-glycosides<
GB1402046A (en) 11,12-epoxyerythromycins
JPS5745162A (en) Substituted 1,2,4,5-tetrahydro-3h,3-benzoazepines
JPS5119733A (en) Nn arukirudai 3 kyuamiruaminno seiho
HK15179A (en) 2,6-diaminoneburlarine derivatives
GB1373077A (en) Benzo-1,3,2-dioxapholphole derivatives
CA977758A (en) Exo-2-phenyl-bicyclo-(2,2,1)-heptane-2-(n-methyl-piperidol-4-)-carbonic-acid-ester and salts thereof
IL42431A0 (en) New substituted-quinolizinium salts and their preparation
AU6046473A (en) 1-aryl-2-arylalkyl-3-or-4%4@-%substituted-alkyl<-piperazino- 1@<-butanols- or-butenes-1
IL43436A0 (en) 11,12-secoprostaglandins and their manufacture
GB1404277A (en) 16,17-seco-d-homosteroids
IL43666A0 (en) Substituted 9,10-dihydro-anthracenes
GB1400789A (en) 1,1-azobis-benzimidazolium salts
IL36977A0 (en) 2,6-methano-3-benzazocines and their preparation
PH10716A (en) O(-dl-4-acetoxy-1-methyl-3,3-diphenylhexylamine and salts
PH9640A (en) Tetraamino-substituted pyrimido-5,4-d-pyrimidines and salts thereof